Inogen (INGN) Asset Writedowns and Impairment (2013 - 2026)
Inogen (INGN) posted quarterly Asset Writedowns and Impairment of $416000.0 for Q1 2026, up 150.6% year-over-year from $166000.0 in Q1 2025, and up 311.88% quarter-over-quarter from $101000.0 in Q4 2025.
Inogen (INGN) Asset Writedowns and Impairment (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Asset Writedowns and Impairment for 14 consecutive years, with $416000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 150.6% year-over-year to $416000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 137.17% YoY), while the FY2025 annual figure was $822000.0, up 252.79% from the prior year.
- Asset Writedowns and Impairment climbed to $416000.0 in Q1 2026 per INGN's latest filing, from $101000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.4 million in Q3 2023 and bottomed at -$317000.0 in Q3 2024.
- Historically, Asset Writedowns and Impairment has averaged $387352.9 across 5 years, with a median of $363000.0 in 2022.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment slumped 123.41% — and 2025, when it soared 413.21%.
- Inogen's Asset Writedowns and Impairment stood at $363000.0 in 2022, then retreated by 4.13% to $348000.0 in 2023, then jumped by 36.78% to $476000.0 in 2024, then tumbled by 78.78% to $101000.0 in 2025, then soared by 311.88% to $416000.0 in 2026.
- Business Quant data shows INGN's Asset Writedowns and Impairment at $416000.0 in Q1 2026, $101000.0 in Q4 2025, and $274000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Inogen | 152.26 Mn | 46.72 Mn | 43.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 265,000.00 |
| Jun 30, 2026 | 265,000.00 |
| Mar 31, 2026 | 416,000.00 |
| Mar 31, 2026 | 416,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 476,000.00 |
| Dec 31, 2024 | 476,000.00 |
| Sep 30, 2024 | -317,000.00 |
| Sep 30, 2024 | -317,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | -53,000.00 |
| Mar 31, 2024 | -53,000.00 |